Anti-CD3 & SSTR2 Antibody (Tidutamab)
Catalog No.
F1179
Anti-CD3 & SSTR2 Antibody (Tidutamab)
Featured Products
Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting the SSTR2 binding domain and the T cell binding domain (CD3). Tidutamab has an intact Fc domain to maintain a long serum half-life. Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cell-mediated cytotoxicity (RTcC).
147.36 kDa
Dry ice
2148354-90-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
XMAB-18087, SSTR2 X CD3
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P07766 & P30874
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD3 & SSTR2
Please avoid freeze-thaw cycles.